Log In
Print
BCIQ
Print
Print this Print this
 

MCLA-128

  Manage Alerts
Collapse Summary General Information
Company Merus B.V.
DescriptionADCC-enhanced human common light chain bispecific IgG1 antibody targeting HER2 and HER3
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu) ; Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today